Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study

被引:117
作者
Kato, K. [1 ]
Sun, J-M. [2 ]
Shah, M. A. [3 ]
Enzinger, P. C. [4 ]
Adenis, A. [5 ]
Doi, T. [6 ]
Kojima, T. [7 ]
Metges, J-P. [8 ]
Li, Z. [9 ]
Kim, S-B. [10 ]
Cho, B. C. Chul [11 ]
Mansoor, W. [12 ]
Li, S-H. [13 ,14 ]
Sunpaweravong, P. [15 ]
Maqueda, M. A. [16 ]
Goekkurt, E. [17 ,18 ]
Liu, Q. [19 ]
Shah, S. [19 ]
Bhagia, P. [19 ]
Shen, L. [20 ]
机构
[1] Natl Canc Ctr, Gastrointestinal Med Oncol, Tokyo, Japan
[2] Sungkyunkwan Univ, Samsung Med Ctr, Med, Seoul, South Korea
[3] Weill Cornell Med Coll, Med Oncol Solid Tumor Program, New York, NY USA
[4] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
[5] Univ Montpellier, ICM, INSERM, Med Oncol,IRCM, Montpellier, France
[6] Natl Canc Ctr Hosp East, Expt Therapeut, Chiba, Japan
[7] Natl Canc Ctr Hosp East, Gastroenterol & Gastrointestinal Oncol, Chiba, Japan
[8] CHU Brest, Inst Cancerol & Hematol, Canc Inst, Brest, France
[9] Shanghai Chest Hosp, Esophageal Dis Ctr, Thorac & Esophageal Surg, Shanghai, Peoples R China
[10] Asan Med Ctr, Oncol, Seoul, South Korea
[11] Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Canc Ctr, Seoul, South Korea
[12] Christie Hosp NHS Trust, Med Oncol, Manchester, Lancs, England
[13] Kaohsiung Chang Gung Mem Hosp, Oncol & Hematol, Kaohsiung, Taiwan
[14] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan
[15] Prince Songkla Univ Hosp, Med, Songkhla, Thailand
[16] Vall dHebron Inst Oncol, Med Oncol, Barcelona, Spain
[17] Hematol Oncol Practice Eppendorf, Hematol Oncol, Hamburg, Germany
[18] Univ Canc Ctr Hamburg, Hamburg, Germany
[19] Merck Sharp & Dohme Corp, Med Oncol, Kenilworth, NJ USA
[20] Peking Univ Canc Hosp & Inst, Gastrointestinal Oncol, Beijing, Peoples R China
关键词
D O I
10.1016/j.annonc.2020.08.2298
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA8_PR
引用
收藏
页码:S1192 / S1193
页数:2
相关论文
empty
未找到相关数据